Stock Comparison
TAK vs UTHR
Takeda Pharmaceutical Co Ltd ADR and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.20B
$21.87B
P/E (TTM)
—
18.3
Forward P/E
10.6
18.6
Price/Sales
0.0
6.9
Price/Book
1.2
3.4
EV/EBITDA
22.6
11.1
Dividend Yield
1.85%
—
Profitability
Net Margin
4.25%
41.56%
Operating Margin
10.89%
44.49%
Return on Equity
-2.26%
19.30%
Return on Assets
2.69%
11.60%
Growth (YoY)
Revenue Growth
10.20%
-1.90%
Earnings Growth
-9.80%
13.40%
Price & Risk
Beta
0.1
0.6
52-Week High
$18.80
$596.76
52-Week Low
$13.23
$304.76
Analyst Target
$21.59
$658.08
Compare TAK and UTHR your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.